Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.
about
CRIF1 interacting with CDK2 regulates bone marrow microenvironment-induced G0/G1 arrest of leukemia cellsThe roles of mesenchymal stem cells in tumor inflammatory microenvironmentA phase I-II trial of fludarabine, bendamustine and rituximab (FBR) in previously treated patients with CLL.Preclinical and clinical evaluation of forodesine in pediatric and adult B-cell acute lymphoblastic leukemiaPhase 2 and pharmacodynamic study of oral forodesine in patients with advanced, fludarabine-treated chronic lymphocytic leukemia.Impact of bone marrow stromal cells on Bcl-2 family members in chronic lymphocytic leukemia.Regulation of Mcl-1 expression in context to bone marrow stromal microenvironment in chronic lymphocytic leukemia.Cancer associated fibroblasts in hematological malignancies.The phosphoinositide-3-kinase (PI3K)-delta and gamma inhibitor, IPI-145 (Duvelisib), overcomes signals from the PI3K/AKT/S6 pathway and promotes apoptosis in CLL.Study of the quantitative, functional, cytogenetic, and immunoregulatory properties of bone marrow mesenchymal stem cells in patients with B-cell chronic lymphocytic leukemia.Synergistic apoptotic response between valproic acid and fludarabine in chronic lymphocytic leukaemia (CLL) cells involves the lysosomal protease cathepsin BSTAT3 and NF-κB cooperatively control in vitro spontaneous apoptosis and poor chemo-responsiveness in patients with chronic lymphocytic leukemia.Reactivation of Smac-mediated apoptosis in chronic lymphocytic leukemia cells: mechanistic studies of Smac mimetic.Inflammation and survival pathways: chronic lymphocytic leukemia as a model system.New nucleoside analogs for patients with hematological malignancies.Treatment of chronic lymphocytic leukemia requires targeting of the protective lymph node environment with novel therapeutic approaches.Mesenchymal niches of bone marrow in cancer.The role of mesenchymal stem cells in anti-cancer drug resistance and tumour progression.Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells.Enhancement of the anti-tumor activity of therapeutic monoclonal antibodies by CXCR4 antagonists.Macrophages confer survival signals via CCR1-dependent translational MCL-1 induction in chronic lymphocytic leukemia.Survival of de novo and secondary acute promyelocytic leukemia: a propensity-matched analysis of the SEER database.Healthy CD4+ T lymphocytes are not affected by targeted therapies against the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia.Cytogenetic and molecular cytogenetic profile of bone marrow-derived mesenchymal stromal cells in chronic and acute lymphoproliferative disorders.Extracellular vesicles as regulators of tumor fate: crosstalk among cancer stem cells, tumor cells and mesenchymal stem cells.Distinct protein signatures of acute myeloid leukemia bone marrow-derived stromal cells are prognostic for patient survival.Hypoxia enhances the radioresistance of mouse mesenchymal stromal cells.Biological and metabolic effects of IACS-010759, an OxPhos inhibitor, on chronic lymphocytic leukemia cells.
P2860
Q24336990-03D38261-734B-4F23-ADD0-4DA55D04087FQ26823759-D02CA14F-638B-4B88-87F3-A6EB95842017Q33591830-9BEC2277-A085-421F-8297-EBD365E24ED1Q33916091-01487342-282A-4563-8B28-1C639A47F429Q34022228-DB5DE1EF-DF18-4464-AC4A-DC216023F60AQ34231324-474036EF-293B-42B9-9329-889DC618A7D9Q35022490-82A5D7C8-C5D5-49FB-84AE-5F888A14DB5BQ35550041-87B83630-C462-429D-B2FA-29054A0BBCF3Q36021849-0C18C8B5-046B-4BF7-98C1-149A070EA304Q36776849-6F683283-6B29-4518-A697-D64002C70765Q37275725-5A75B7E1-57D9-4A89-B0CE-AD31BF6BFF8EQ37362593-3473CAF4-C858-41A6-B634-DB23B19B2D29Q37457562-D09D9D50-706C-435E-BBDB-E5C830B3A610Q37778876-C0949509-0A2F-4879-AFDB-D794A9C00164Q37841589-6A3334C9-6F99-432E-8206-269A5EA0C0F5Q37910914-333CE62D-4A9C-4925-AA68-5709DE61562FQ37921954-70E60596-40BE-4E83-A2FA-5E0988A03D92Q38010997-4C1977A6-7517-42A1-9319-70F5C1786C97Q38736947-16A062CB-EDA4-44F9-B45D-CF9078CD58C3Q39510365-EABD3137-138B-4EA3-B363-933921B45DD4Q40338396-ED5A7B86-AB4B-4FF7-9167-AE94B71F0388Q41662169-7F9589C0-F82D-4499-B6B6-42108F5C10D2Q42317505-EB812E0A-AA1F-4007-A8A1-B99086A872CBQ43984170-796B2773-4BF7-40EB-ACDD-A28097C8612EQ47148289-944BA682-CC91-4152-B805-CE3F3A95EA87Q52653312-E6F7F8E4-9A69-412B-B04B-98A45D9D5EAEQ53064517-3432A1C4-9472-41ED-AF94-820F9289ABF1Q55027218-95BB7B2F-C002-4F85-9525-C0D6ACB49CFD
P2860
Influence of bone marrow stromal microenvironment on forodesine-induced responses in CLL primary cells.
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Influence of bone marrow strom ...... esponses in CLL primary cells.
@ast
Influence of bone marrow strom ...... esponses in CLL primary cells.
@en
Influence of bone marrow strom ...... esponses in CLL primary cells.
@nl
type
label
Influence of bone marrow strom ...... esponses in CLL primary cells.
@ast
Influence of bone marrow strom ...... esponses in CLL primary cells.
@en
Influence of bone marrow strom ...... esponses in CLL primary cells.
@nl
prefLabel
Influence of bone marrow strom ...... esponses in CLL primary cells.
@ast
Influence of bone marrow strom ...... esponses in CLL primary cells.
@en
Influence of bone marrow strom ...... esponses in CLL primary cells.
@nl
P2093
P2860
P1433
P1476
Influence of bone marrow strom ...... esponses in CLL primary cells.
@en
P2093
Jan A Burger
Kumudha Balakrishnan
Maite P Quiroga
Marina Henneberg
Mary L Ayres
Varsha Gandhi
P2860
P304
P356
10.1182/BLOOD-2009-10-246199
P407
P577
2010-05-04T00:00:00Z